2018
DOI: 10.1111/jcmm.14039
|View full text |Cite
|
Sign up to set email alerts
|

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma

Abstract: Lysyl oxidase‐like 2 (LOXL2) has shown to promote metastasis and poor prognosis in hepatocellular carcinoma (HCC). Also, we have previously reported that vasculogenic mimicry (VM) is associated with invasion, metastasis and poor survival in HCC patients. In the present study, we investigated molecular function of LOXL2 in HCC and VM. We used the immunohistochemical and CD31/periodic acid‐Schiff double staining to detect the relationship between LOXL2 and VM formation. We performed the gain and loss of function… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
47
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(47 citation statements)
references
References 40 publications
0
47
0
Order By: Relevance
“…Our bio-informatic analysis identified 25 hypoxia upregulated genes in chronic HBV infected patients, including LOXL2, SMIM3, TNS1, and IGFBP1. Notably, LOXL2 overexpression in HCC was previously associated with high tumour grade, metastasis, and poor patient overall and disease-free survival 59 . LOXL2 was shown to mediate its pathogenic effects in HCC angiogenesis via vasculogenic mimicry signalling, cytoskeleton reorganization, and bone-marrow derived cell recruitment 59,60 .…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…Our bio-informatic analysis identified 25 hypoxia upregulated genes in chronic HBV infected patients, including LOXL2, SMIM3, TNS1, and IGFBP1. Notably, LOXL2 overexpression in HCC was previously associated with high tumour grade, metastasis, and poor patient overall and disease-free survival 59 . LOXL2 was shown to mediate its pathogenic effects in HCC angiogenesis via vasculogenic mimicry signalling, cytoskeleton reorganization, and bone-marrow derived cell recruitment 59,60 .…”
Section: Discussionmentioning
confidence: 97%
“…Notably, LOXL2 overexpression in HCC was previously associated with high tumour grade, metastasis, and poor patient overall and disease-free survival 59 . LOXL2 was shown to mediate its pathogenic effects in HCC angiogenesis via vasculogenic mimicry signalling, cytoskeleton reorganization, and bone-marrow derived cell recruitment 59,60 . In fact, hypoxia and HIF-1α signalling have been identified as key regulators of LOXL2 and driver of its pathogenesis, consistent with our observations 60,61 .…”
Section: Discussionmentioning
confidence: 97%
“…Our bio-informatic analysis identified 25 hypoxia upregulated genes in chronic HBV infected patients, including LOXL2, SMIM3, TNS1 , and IGFBP1 . Notably, LOXL2 overexpression in HCC was previously associated with high tumour grade, metastasis, and poor patient overall and disease-free survival 52 . LOXL2 was shown to mediate its pathogenic effects in HCC angiogenesis via vasculogenic mimicry signalling, cytoskeleton reorganization, and bone-marrow derived cell recruitment 52,53 .…”
Section: Discussionmentioning
confidence: 97%
“…Notably, LOXL2 overexpression in HCC was previously associated with high tumour grade, metastasis, and poor patient overall and disease-free survival 52 . LOXL2 was shown to mediate its pathogenic effects in HCC angiogenesis via vasculogenic mimicry signalling, cytoskeleton reorganization, and bone-marrow derived cell recruitment 52,53 . In fact, hypoxia and HIF-1α signalling have been identified as key regulators of LOXL2 and driver of its pathogenesis, consistent with our observations 53,54 .…”
Section: Discussionmentioning
confidence: 97%
“…In recent years, more and more importance has been attributed to the phenomenon called vasculogenic mimicry (VM). Although the prevalence and importance of VM in cancer still divides the scientific community [ 141 , 142 ], evidence confirms that this process is associated with poor prognosis in cancer patients [ 143 , 144 , 145 ]. However, there is no detailed description of changes in the actin structure in the course of this phenomenon so far.…”
Section: Role Of Actin In Angiogenesis and Vasculogenic Mimicrymentioning
confidence: 99%